Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print St. Jude defines eye cancer gene's role in retinal development

St. Jude defines eye cancer gene's role in retinal development

January 17, 2008

Study provides the foundation for improving understanding of N-Myc gene's role in the eyes' growth during fetal development when retinoblastoma forms

A genetic discovery led by scientists at St. Jude Children's Research Hospital helps answer a long-standing mystery about the eyes of vertebrates, and may translate into a deeper understanding of how genes coordinate the complex process of eye formation and how a rare pediatric eye cancer progresses.




"A series of complex developmental processes must be carefully orchestrated for the eye to form correctly," said Michael Dyer, Ph.D., associate member in the St. Jude Department of Developmental Neurobiology. "One important aspect of this coordination is that retinal thickness be the same, irrespective of eye size. For example, the mouse eye is about 5,000 times smaller than that of the elephant eye, but the retinal thickness in these two species is comparable."

Working with mice, the researchers found that a gene called N-myc coordinates the growth of the retina and other eye structures to ensure the retina has the proper thickness necessary to convert light from the lens into nerve impulses that the brain transforms into images. Until their study, reported in the Jan. 15 issue of "Genes & Development," almost nothing was known about the molecular mechanisms responsible for properly sizing the retina. Dyer is the paper's senior author.

"This represents the first example of a role for a Myc gene in retinal development," Dyer said. "On the basis of our data, we propose that N-myc plays a central role in coordinating retinal proliferation with eye growth during development."

Genes in the Myc family carry out vital roles during prenatal development by regulating the proliferation, size, differentiation and survival of cells. Myc genes are also proto-oncogenes-genes in which a mutation enables them to transform normal cells into cancerous ones. Malfunctioning N-myc genes are often associated with pediatric neural cancers, including neuroblastoma, medulloblastoma and retinoblastoma.

Recently, Dyer and his team identified the specific type of cell that gives rise to retinoblastoma, a potentially fatal malignant tumor in the retina that affects about 300 children in the United States annually. "The determination of N-myc target genes during retinal development may also contribute to the current understanding of retinoblastoma progression," he said.

In the course of their study, the researchers discovered that N-myc is not involved in regulating cell survival or neuronal differentiation in the developing retina. However, the gene is crucial for the proper proliferation of retinal cells. In mice in which the scientists inactivated N-myc, the volume of the retina was significantly smaller than in mice with normally functioning N-myc.

The team found no evidence of an increase in progenitor cell deaths between normal and N-myc-deficient retinas. The investigators then concluded the smaller retinas likely resulted from an N-myc-related proliferation defect in the progenitor retinal cells.

The researchers hypothesize that N-myc's activity occurs early in the cascade of reactions that control development of the retina and other eye components. Therefore, when something inactivates the gene, the result is both a reduction in retinal progenitor cell proliferation and a reduction in the signaling cues that coordinate the growth of the eye and retina.

"Importantly, for retinas to maintain nearly constant thickness across species that have different sizes of eyes, the total number of retinal cells must change several-fold," Dyer said. "The identification of N-myc as a key regulator of these processes allows us to begin to understand the coordination of complex developmental programs in the developing eye and how these processes have evolved."

St. Jude Children's Research Hospital



Related Retinal Cells Current Events and Retinal Cells News Articles Retinal Cells Current Events and Retinal Cells News RSS Retinal Cells Current Events and Retinal Cells News RSS
Sight gone, but not necessarily lost?
Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness.

First in New York: Bionic technology aims to give sight to woman blinded beginning at age 13
A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision.

Experimental treatments restore partial vision to blind people
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind.

Researchers discover mechanism that helps humans see in bright and low light
Ever wonder how your eyes adjust during a blackout? When we go from light to near total darkness, cells in the retina must quickly adjust. Vision scientists at Washington University School of Medicine in St. Louis have identified an intricate process that allows the human eye to adapt to darkness very quickly. The same process also allows the eye to function in bright light.

UF scientists program blood stem cells to become vision cells
University of Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people.

Omega-3 fatty acids appear to impact AMD progression
Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken.

New insight into primate eye evolution
Researchers comparing the fetal development of the eye of the owl monkey with that of the capuchin monkey have found that only a minor difference in the timing of cell proliferation can explain the multiple anatomical differences in the two kinds of eyes.

Eye cells believed to be retinal stem cells are misidentified
Cells isolated from the eye that many scientists believed were retinal stem cells are, in fact, normal adult cells, investigators at St. Jude Children's Research Hospital have found.

'Dark Cells' of Living Retina Imaged for the First Time
A layer of "dark cells" in the retina that is responsible for maintaining the health of the light-sensing cells in our eyes has been imaged in a living retina for the first time.

Mammals can be stimulated to regrow damaged inner retina nerve cells
Researchers at the University of Washington (UW) have reported for the first time that mammals can be stimulated to regrow inner nerve cells in their damaged retinas. Located in the back of the eye, the retina's role in vision is to convert light into nerve impulses to the brain.
More Retinal Cells Current Events and Retinal Cells News Articles
The Retinal Muller Cell: Structure & Function (Perspectives in Vision Research)

The Retinal Muller Cell: Structure & Function (Perspectives in Vision Research)
by Vijay Sarthy (Author), Harris Ripps (Author)

This monograph examines the role of the Muller cell, the main glial element of the retina, in the development, organization, and function of the vertebrate retina. These cells may also play a role in the control of eye growth and in determining the processing of information by surrounding neurons.

The Aging Eye: New Therapies for Age Related Macular Degeneration

The Aging Eye: New Therapies for Age Related Macular Degeneration

In the past two years, there have been rapid and dramatic improvements in the treatment of macular degeneration which is the leading cause of blindness in the United States in persons over age 65. In this lecture, Mark Blumenkranz, MD covers new advances in this disease that have changed our understanding and approach to it. Mark S. Blumenkranz, MD, is Professor and Chairman of the Department of Ophthalmology at Stanford University. He is the author of more than 100 peer-reviewed publications and book chapters in the area of vitreoretinal surgery, with special interests in surgical adjuvant pharmacology and new microsurgical and laser techniques. Dr. Blumenkranz was instrumental in developing the successful laser vision correction program at Stanford and serves as a principal...

  Central retinal vein occlusion in sickle cell disease.(Case Report): An article from: Southern Medical Journal
by Syed Hasan (Author), Mamoon Elbedawi (Author), Oswaldo Castro (Author), Mark Gladwin (Author), Alan Palestine (Author)

This digital document is an article from Southern Medical Journal, published by Southern Medical Association on February 1, 2004. The length of the article is 1952 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Central retinal vein occlusion in sickle cell disease.(Case Report)
Author: Syed Hasan
Publication: Southern Medical Journal (Refereed)
Date: February 1, 2004
Publisher: Southern Medical Association
Volume: 97 Issue: 2 Page: 202(3)

Distributed by Thomson...

  Parallel Processing in the Visual System: The Classification of Retinal Ganglion Cells and Its Impact on the Neurobiology of Vision (Perspectives in Vision Research)
by Jonathan Stone (Author)



  Attenuated superoxide dismutase induction in retinal cells in response to intermittent high versus continuous high glucose.(Report): An article from: American Journal of Biochemistry and Biotechnology
by Michael A. Ihnat (Author), Ronald C. Kaltreider (Author), Jessica E. Thorpe (Author), Dixy E. Green (Author), Chandrashekhar D. Kamat (Author), Melissa Leeper (Author), Amanda C. Shanner (Author), Linda A. Warnke (Author), Ludovica Piconi (Author), Antonio Ceriello (Author)

This digital document is an article from American Journal of Biochemistry and Biotechnology, published by Thomson Gale on January 1, 2007. The length of the article is 5127 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Attenuated superoxide dismutase induction in retinal cells in response to intermittent high versus continuous high glucose.(Report)
Author: Michael A. Ihnat
Publication: American Journal of Biochemistry and Biotechnology (Magazine/Journal)
Date: January 1, 2007
Publisher: Thomson Gale
Volume: 3 Issue: 1 Page: 16(8)

Article Type:...

  Levodopa-producing retinal cell implants show Parkinson's benefit.(Clinical Rounds): An article from: Family Practice News
by Mary Ann Moon (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on January 15, 2006. The length of the article is 484 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Levodopa-producing retinal cell implants show Parkinson's benefit.(Clinical Rounds)
Author: Mary Ann Moon
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 2 Page: 75(1)

Distributed by Thomson...

  Neurophysiological Aspects of Color Vision in Primates: Comparative Studies in Simiarn Retinal Ganglion Cells and Human Visual System : Studies in Br (Studies of Brain Function)
by Eberhart Zrenner (Author)



  THE RETINAL GANGLION CELL LAYER.
by J. M. van. Buren (Author)



  Mechanisms of Retinal Ganglion Cell Death in Glaucom
by Martin Keith (Author)



Mechanisms of retinal ganglion cell death in glaucoma: New approaches to the pathogenesis and treatment of the silent thief of sight

Mechanisms of retinal ganglion cell death in glaucoma: New approaches to the pathogenesis and treatment of the silent thief of sight
by Keith Martin (Author)

Elevated intraocular pressure is the most significant risk factor in glaucoma but the mechanisms of retinal ganglion cell death in remain incompletely understood. Animal models of glaucoma provide a way to study the possible pathogenesis of glaucomatous retinal ganglion cell death and to assess potential neuroprotective strategies. In this volume, Dr Keith Martin describes in detail how a trabecular laser glaucoma model can be used to study changes occuring in the retina and optic nerve of eyes with elevated intraocular pressure. The possible involvement of retinal glutamate transporters in glaucoma is explored, hinting at possible new treatment approaches. Dr Martin goes on to describe in detail the techniques that led to the first successful use of neurotrophic...

© 2009 BrightSurf.com